Literature DB >> 15526756

Osteopontin is strongly expressed by alveolar macrophages in the lungs of acute respiratory distress syndrome.

Fumiyuki Takahashi1, Kazuhisa Takahashi, Kazue Shimizu, Ri Cui, Norihiro Tada, Hideki Takahashi, Sanae Soma, Masakata Yoshioka, Yoshinosuke Fukuchi.   

Abstract

Acute respiratory distress syndrome (ARDS) is characterized by an intense inflammatory response in the lung parenchyma. Recent studies suggest that excessive nitric oxide (NO) production mediated by inducible NO synthase (iNOS) in macrophages is partially involved in mediating acute lung injury in ARDS. On the other hand, osteopontin (OPN) is a cytokine which is capable of inhibiting NO production by suppressing iNOS mRNA expression in macrophages. In this study, we investigated the expression of OPN in the lungs of 10 patients with ARDS. In most patients, OPN is strongly expressed on alveolar macrophages. In addition, we produced a murine model for ARDS by intratracheal administration of lipopolysaccharide and investigated the expression of endogenous OPN and iNOS in the lungs of ARDS mice. Immunostaining demonstrated that in vivo OPN protein was coinduced with iNOS protein predominantly in the accumulating alveolar macrophages. OPN mRNA expression was also coinduced with iNOS mRNA, but was induced more slowly than iNOS mRNA in the lungs of ARDS mice. These results suggested that OPN, which may reduce NO production of macrophages by inhibiting iNOS expression, is significantly induced and expressed on alveolar macrophages in the lungs of ARDS. It is possible that OPN is partially involved in playing a protective role against excessive production of NO in ARDS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526756     DOI: 10.1007/s00408-004-0309-1

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  32 in total

Review 1.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

Review 2.  Neutrophil kinetics and lung injury.

Authors:  J C Hogg
Journal:  Physiol Rev       Date:  1987-10       Impact factor: 37.312

3.  Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase.

Authors:  K Singh; J L Balligand; T A Fischer; T W Smith; R A Kelly
Journal:  J Biol Chem       Date:  1995-11-24       Impact factor: 5.157

4.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Osteopontin is induced by nitric oxide in RAW 264.7 cells.

Authors:  F Takahashi; K Takahashi; K Maeda; S Tominaga; Y Fukuchi
Journal:  IUBMB Life       Date:  2000-03       Impact factor: 3.885

6.  Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome.

Authors:  C Sittipunt; K P Steinberg; J T Ruzinski; C Myles; S Zhu; R B Goodman; L D Hudson; S Matalon; T R Martin
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

7.  Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome.

Authors:  C T Lee; A M Fein; M Lippmann; H Holtzman; P Kimbel; G Weinbaum
Journal:  N Engl J Med       Date:  1981-01-22       Impact factor: 91.245

Review 8.  Osteopontin: a protein with diverse functions.

Authors:  D T Denhardt; X Guo
Journal:  FASEB J       Date:  1993-12       Impact factor: 5.191

9.  Expression of inducible nitric oxide synthase and inflammatory cytokines in alveolar macrophages of ARDS following sepsis.

Authors:  A Kobayashi; S Hashimoto; K Kooguchi; Y Kitamura; H Onodera; Y Urata; T Ashihara
Journal:  Chest       Date:  1998-06       Impact factor: 9.410

10.  Expression of osteopontin in a macrophage cell line and in transgenic mice with pulmonary fibrosis resulting from the lung expression of a tumor necrosis factor-alpha transgene.

Authors:  Y Miyazaki; T Tashiro; Y Higuchi; M Setoguchi; S Yamamoto; H Nagai; M Nasu; P Vassalli
Journal:  Ann N Y Acad Sci       Date:  1995-04-21       Impact factor: 5.691

View more
  19 in total

1.  Severity predictors in eschar-positive scrub typhus and role of serum osteopontin.

Authors:  Sang-Won Park; Chang-Seop Lee; Chi Kug Lee; Yee Gyung Kwak; Chisook Moon; Baek-Nam Kim; Eu Suk Kim; Jae Myung Kang; Myoung-don Oh
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

Review 2.  Cellular and molecular mechanisms of bone remodeling.

Authors:  Liza J Raggatt; Nicola C Partridge
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

3.  Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model.

Authors:  Sunmi Park; Jack Zhu; Grégoire Altan-Bonnet; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

4.  Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species.

Authors:  Saskia L Smits; Judith M A van den Brand; Anna de Lang; Lonneke M E Leijten; Wilfred F van Ijcken; Geert van Amerongen; Albert D M E Osterhaus; Arno C Andeweg; Bart L Haagmans
Journal:  J Virol       Date:  2011-02-16       Impact factor: 5.103

5.  Modulation of Osteoblastic Cell Efferocytosis by Bone Marrow Macrophages.

Authors:  Megan N Michalski; Amy J Koh; Savannah Weidner; Hernan Roca; Laurie K McCauley
Journal:  J Cell Biochem       Date:  2016-05-05       Impact factor: 4.429

6.  Osteopontin is not crucial to protective immunity during murine tuberculosis.

Authors:  Gerritje J W van der Windt; Catharina W Wieland; Willem J Wiersinga; Sandrine Florquin; Tom van der Poll
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

7.  Adenosine and osteopontin contribute to the development of chronic obstructive pulmonary disease.

Authors:  Daniel J Schneider; Janci C Lindsay; Yang Zhou; Jose G Molina; Michael R Blackburn
Journal:  FASEB J       Date:  2009-08-31       Impact factor: 5.191

8.  Serum levels of osteopontin are increased in SIRS and sepsis.

Authors:  Rosanna Vaschetto; Stefania Nicola; Carlo Olivieri; Elena Boggio; Fabio Piccolella; Riccardo Mesturini; Federica Damnotti; Davide Colombo; Paolo Navalesi; Francesco Della Corte; Umberto Dianzani; Annalisa Chiocchetti
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

9.  Differential response of primary alveolar type I and type II cells to LPS stimulation.

Authors:  Mandi H Wong; Meshell D Johnson
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

10.  Down-regulation of osteopontin attenuates breast tumour progression in vivo.

Authors:  Goutam Chakraborty; Shalini Jain; Tushar V Patil; Gopal C Kundu
Journal:  J Cell Mol Med       Date:  2008-02-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.